Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: A population-based cohort study in Rome, Italy

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 1, 2012, Pages 37-44

  Kirchmayer, U ^a   Agabiti, N ^a   Belleudi, V ^a   Davoli, M ^a   Fusco, D ^a   Stafoggia, M ^a   Arca M ^a   Barone, A P ^a   Perucci, C A ^a  

^a Lazio Region ^*  (Italy)

Author keywords

evidence based pharmacotherapy; patient characteristics; pharmacoepidemiology; prescription records; preventive prescribing; socio economic factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; SOCIAL ASPECT; SOCIOECONOMICS; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84856326397     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01242.x     Document Type: Article

References (36)

1. National Institute for Clinical Excellence. Secondary prevention in primary and secondary care for patients following a myocardial infarction. NICE, 2007; 48: 14-22.
2. AHA; ACC; National Heart, Lung, and Blood Institute, Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. Journal of the American College of Cardiology, 2006; 47 (10): 2130-2139. (Pubitemid 44275145)
3. Briffa T, Hickling S, Knuiman M, et al. Long term survival after evidence-based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ, 2009; 338:b36.
4. Gouya G, Reichardt B, Ohrenberger G, Wolzt M,. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. European Journal of Epidemiology, 2007; 22 (3): 145-149. (Pubitemid 46481324)
5. Yan AT, Yan RT, Tan M, et al. Canadian ACS Registries Investigators. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. American Heart Journal, 2007; 154 (6): 1108-1115. (Pubitemid 350123528)
6. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation, 2006; 113 (2): 203-212.
7. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA,. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation, 2004; 109 (6): 745-749. (Pubitemid 38222894)
8. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH,. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiology and Drug Safety, 2008; 17 (12): 1189-1196.
9. Lee HY, Cooke CE, Robertson TA,. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. Journal of Managed Care Pharmacy, 2008; 14 (3): 271-280. (Pubitemid 351711978)
10. Setoguchi S, Solomon DH, Levin R, Winkelmayer WC,. Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. American Journal of Cardiology, 2008; 101 (11): 1531-1536.
11. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilot L,. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. American Heart Journal, 2003; 145 (3): 438-444. (Pubitemid 36390489)
12. Pilote L, Beck CA, Karp I, et al. Canadian Cardiovascular Outcomes Research Team. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Canadian Journal of Cardiology, 2004; 20 (1): 61-67. (Pubitemid 38292214)
13. Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. American Heart Journal, 2009; 157: 509-516e1.
14. Austin PC, Tu JV, Ko DT, Alter DA,. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction. Canadian Medical Association Journal, 2008; 179 (9): 895-900.
15. Vermeer NS, Bajorek BV,. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Journal of Clinical Pharmacy and Therapeutics, 2008; 33: 591-601.
16. Tuppin P, Neumann A, Danchin N, Weill A, Ricordeau P, de Peretti C, Allemand H,. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database. Archives of Cardiovascular Diseases, 2009; 102 (4): 279-292.
17. Crilly M, Bundred P, Hu X, Leckey L, Johnstone F,. Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care. BMC Health Services Research, 2007; 7:142.
18. Gislason GH, Rasmussen JN, Abildstrøm SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. European Heart Journal, 2006; 27 (10): 1153-1158.
19. Van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A,. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis. Clinical Therapeutics, 2005; 27 (11): 1806-1814. (Pubitemid 41815231)
20. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, and, Keil U, on behalf of the EUROASPIRE Study Group. EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. European Journal of Cardiovascular Prevention and Rehabilitation, 2009; 16 (2): 121-137.
21. Cesaroni G, Agabiti N, Rosati R, Forastiere F, Perucci CA,. An index of socioeconomic position based on 2001 Census, Rome. Epidemiologia e Prevenzione, 2006; 30: 352-357.
22. Ghali WA, Quan H, Brant R,. Risk adjustment using administrative data. Impact of a diagnosis-type indicator. J Ger Intern Med, 2001; 16: 519-524. (Pubitemid 34203390)
23. Austin PC, Tu JV, Ko DT, Alter DA,. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. Canadian Medical Association Journal, 2008; 179 (9): 901-908.
24. Filippi A,. Comitato Promotore della Società Italiana di Medicina Generale. Collaborators (14) [Long-term management of patients at high cardiovascular risk in general practice] [Article in Italian]. Monaldi Archives for Chest Disease, 2009; 72 (4): 179-189.
25. Gnavi R, Migliardi A, Demaria M, Petrelli A, Caprioglio A, Costa G,. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. European Journal of Public Health, 2007; 17 (5): 492-496. (Pubitemid 350033999)
26. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation, 2009; 120 (16): 1598-1605.
27. Herlitz J, Dellborg M, Karlsson T, Evander MH, Hartford M, Perers E, Caidahl K,. Treatment and outcome in acute myocardial infarction in a community in relation to gender. International Journal of Cardiology, 2009; 135: 315-322.
28. Halvorsen S, Eritsland J, Abdelnoor M, et al. Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007. Cardiology, 2009; 114: 83-88.
29. El-Menyar A, Zubaid M, Rashed W, et al. Comparison of men and women with acute coronary syndrome in six Middle Eastern countries. American Journal of Cardiology, 2009; 104 (8): 1018-1022.
30. Jneid H, Fonarow GC, Cannon CP, et al. Get With the Guidelines Steering Committee and Investigators. Sex differences in medical care and early death after acute myocardial infarction. Circulation, 2008; 118 (25): 2803-2810.
31. Peterson ED, Shah BR, Parsons L, et al. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal, 2008; 156: 1045-1055.
32. Ohlsson H, Rosvall M, Hansen O, Chaix B, Merlo J, (2010) Socioeconomic position and secondary preventive therapy after an AMI. Pharmacoepidemiology and Drug Safety, Available at: (accessed 19 January 2010).
33. Maio V, Yuen E, Rabinowitz C, et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. Journal of Health Services Research and Policy, 2005; 10 (4): 232-238. (Pubitemid 41540275)
34. Ancona C, Arcà M, Saitto C, Agabiti N, Fusco D, Tancioni V, Perucci CA,. Differences in access to coronary care unit among patients with acute myocardial infarction in Rome: old, ill, and poor people hold the burden of inefficiency. BMC Health Services Research, 2004; 4:34, (accessed 20 July 2010).
35. Picciotto S, Forastiere F, Stafoggia M, D'Ippoliti D, Ancona C, Perucci CA,. Associations of area based deprivation status and individual educational attainment with incidence, treatment, and prognosis of first coronary event in Rome, Italy. Journal of Epidemiology and Community Health, 2006; 60: 37-43. (Pubitemid 43028628)
36. Vegni FE, Wilkinson P,. Patterns of respiratory drug use in the Lombardy region of Italy, 1995-1997. European Journal of Epidemiology, 2006; 21 (7): 537-44. (Pubitemid 44578331)